Study Design. Retrospective analysis of a prospectively maintained surgical registry. Objective. To compare postoperative narcotic consumption between multimodal analgesia (MMA) and patient-controlled analgesia (PCA) after an anterior cervical discectomy and fusion (ACDF). Summary of Background Data. Studies suggest that a multimodal approach to pain management leads to decreased pain and morphine consumption after total joint arthroplasty and lumbar spinal procedures. Patients and surgeons would benefit from knowing whether a multimodal approach to pain management is superior to PCA for ACDF. Methods. A retrospective cohort study of ACDF patients receiving either MMA or PCA was conducted. Inpatient narcotic consumption, pain scores, nausea/vomiting, hospital length of stay, and narcotic dependence during the months after surgery were compared between MMA and PCA. Results. A total of 239 patients met inclusion criteria. Of these, 55 (23.0%) received MMA and 184 (77.0%) received PCA. Patients who received MMA had a lower rate of inpatient narcotic consumption (2.5 OME/h vs. 5.8 OME/h, P < 0.001) were less likely to experience nausea/vomiting during the hospitalization (5.5% vs. 37.5%, P < 0.001), and had a shorter hospital length of stay (27.3 vs. 40.1 h, P < 0.001). However, there was no difference between groups in mean visual analogue pain scale during postoperative day zero (4.7 for MMA vs. 5.2 for PCA, P ¼ 0.126) or during postoperative day one (4.1 for MMA vs. 4.1 for PCA, P ¼ 0.937). In addition, there was no difference in the rate of narcotic dependence at the first (P ¼ 0.626) or second (P ¼ 0.480) postoperative visits. Conclusion. These data suggest that MMA results in lower narcotic consumption than PCA after an ACDF. This difference is associated with a shorter inpatient stay and a decrease in postoperative nausea/vomiting. Critically, MMA and PCA appear to provide similar postoperative analgesia.
M oderate-to-severe postoperative pain is a common complaint and concern for many patients. 1 Unrelieved pain initiates a stress response cascade, which can delay recovery. 2 The most effective regimen to address early postoperative pain remains controversial in many surgical subspecialties.
One common technique to address pain after surgery is patient-controlled analgesia (PCA). PCA refers to any method that allows the patient to self-administer narcotic medication. Although very effective at relieving pain, narcotic analgesics can have severe side effects including nausea, vomiting, confusion, constipation, urinary retention, dizziness, sedation, respiratory depression, and pruritus. Another form of postoperative pain control is called multimodal analgesia (MMA). MMA attempts to capture the effectiveness of individual analgesic agents in optimal dosages to maximize efficacy. By limiting the dosage of each analgesic, it is thought that side effects can be minimized.
Anterior cervical discectomy and fusion (ACDF) is a commonly performed procedure for several common spinal pathologies. [3] [4] [5] While several studies have examined the results of MMA after total joint arthroplasty (TJA) procedures, [6] [7] [8] [9] [10] [11] lumbar spinal procedures, 12, 13 and heterogeneous collections of spinal procedures, 14 little has been published regarding its utilization after ACDF. As such, the purpose of this study was to compare the use of MMA versus PCA in patients undergoing an ACDF.
MATERIALS AND METHODS

Data Collection
A prospectively maintained surgical registry was retrospectively reviewed to identify all patients undergoing an ACDF with a single surgeon during 2009 to 2014. Patients were categorized as receiving either PCA (Table 1) or MMA ( Table 2 ). There were no specific selection criteria for whether a patient received PCA or MMA during their hospitalization. Patients were initially randomized into each cohort; however, poor enforcement of each protocol by the hospital staff resulted in a modification to assignment by patient choice. Patients from that point forward were educated on the options and selected the protocol they felt comfortable with for their postoperative care.
The major differences between the protocols occurred on postoperative day (POD) 0. In the PCA protocol, POD 0 medications included: fentanyl citrate, cyclobenzaprine, and morphine PCA. The morphine PCA parameters were: 30 mg/30 mL syringe with a loading dose of 0 or 1 mg, followed by a PCA dose of 1 mg with a 4-hour dose limit of 30 mg. In the MMA protocol, POD 0 medications included tramadol, hydrocodone/paracetamol, cyclobenzaprine, pregabalin, and oxycodone. In the MMA protocol, patients also regularly received cryotherapy (ice packs applied to the neck). The protocols in Tables 1 and 2 describe the pain control methods that each patient was guaranteed to receive. In the case of icepacks, each MMA patient received icepacks as part of their protocol. Icepacks were also made available to patients in the PCA cohort, but their use was optional based on patient preference.
The Charlson comorbidity index (CCI; excluding the age component) was determined for each patient. The age component was excluded such that age and comorbidity could be analyzed independently.
Total inpatient narcotic consumption in oral morphine equivalent (OME) was calculated for each patient. To calculate the average rate of narcotic consumption during the inpatient stay, the OME was divided by the hospital length of stay (OME/h).
Postoperative pain was characterized using the nursingrecorded visual analogue scale (VAS). A maximum of one VAS measurement was recorded per hour, and the VAS measurements were then averaged across the course of each Finally, the Illinois Prescription Monitoring System was accessed to investigate the filling of narcotic prescriptions. Narcotic dependence at the first (6 postoperative weeks) or second (12 postoperative weeks) postoperative visit was determined on the basis of the filling of narcotic prescriptions during the 6 weeks after each of these visits.
Data Analysis
Inpatient narcotic consumption, occurrence of nausea/vomiting, mean VAS on POD 0, mean VAS on POD 1, hospital length of stay, and narcotic dependence at the first and second postoperative visits were compared between MMA and PCA. T tests were applied to evaluate continuous outcomes (rate of inpatient narcotic consumption, VAS, and length of stay). Pearson's x 2 test was used to evaluate binary outcomes (occurrence of nausea/vomiting and narcotic dependence at postoperative visits). All tests were two-tailed and the level of significance was set at P < 0.05.
RESULTS
A total of 239 patients met inclusion criteria. Of these, 55 (23.0%) received MMA and 184 (77.0%) received PCA. The majority of baseline characteristics did not differ between groups (Table 3) . However, patients who received MMA had a lower rate of smoking (9% vs. 23%, P ¼ 0.025) and a lower comorbidity burden (CCI of 1.0 vs. 1.7, P < 0.001) than patients who received PCA.
Compared with patients who received PCA, patients who received MMA had a lower rate of inpatient narcotic consumption (2.5 vs. 5.8 OME/h, P < 0.001), a lower rate of nausea/vomiting during the inpatient stay (5.5% vs. 37.5%, P < 0.001), and a shorter hospital length of stay (27.3 vs. 40.1 h, P < 0.001). There was no difference between groups in mean VAS during POD 0 (4.7 for MMA vs. 5.2 for PCA, P ¼ 0.126) or during POD 1 (4.1 for MMA vs. 4.1 for PCA, P ¼ 0.937) (Table 4) .
Overall, there was no difference in the rate of narcotic dependence at the first postoperative visit between patients who received MMA and patients who received PCA (51.9% vs. 55.7%, P ¼ 0.626). Similarly, there was no difference in the rate of narcotic dependence at the second postoperative visit between patients who received MMA and patients who received PCA (30.8% vs. 36.1%, P ¼ 0.480) ( Table 4) .
DISCUSSION
This study found that patients undergoing ACDF had lower narcotic consumption during the inpatient stay with the use of a multimodal analgesia protocol. This decrease in narcotic consumption was associated with a shorter hospital length of stay and a decrease in the number of episodes of nausea/vomiting during the hospitalization, while maintaining similar pain relief.
The reduction in narcotic consumption in MMA patients who underwent ACDF was similar to findings in total joint arthroplasty (TJA) 6, 15, 16 and spine. [12] [13] [14] For example, Mathiesen et al 12 applied a similar MMA algorithm to patients undergoing multilevel lumbar spine surgery. In their retrospective study, the authors found that MMA resulted in decreased opioid consumption, decreased rates of nausea/ vomiting, and improved postoperative mobilization. 12 Similarly, in a prospective, randomized study of patients undergoing lumbar decompression surgery, Garcia et al 13 described significantly reduced narcotic consumption and decreased VAS in patients receiving MMA. Finally, in a retrospective study after implementation of a new MMA protocol at their institution, Rajpal et al 14 found a decrease in nausea, drowsiness, and cough in patients receiving MMA after a heterogeneous group of spinal procedures.
In the present study of exclusively patients undergoing ACDF, length of stay was shorter in patients receiving MMA. Narcotic medications increase drowsiness in patients and so may delay ambulation, potentially explaining at least part of this difference. Notably, Berger et al 8 described how their MMA protocol for total hip arthroplasty allowed patients to participate in immediate postoperative physical therapy. Compared with their patients who received intravenous morphine for pain control and typically spent the night in the hospital, patients who received MMA more often met discharge requirements on the day of surgery. Other studies have had similar results. One side effect of opioid medications is nausea and vomiting. 19 It is likely that the higher rate of nausea/vomiting observed in PCA patients in the present study is a direct result of the higher doses of narcotic analgesics that PCA patients received. Nausea/vomiting is an unpleasant side effect that should be minimized. The ability to receive medication by mouth is often considered to be a discharge requirement after surgery. As a result, patients with nausea/ vomiting may remain in the hospital longer, potentially explaining at least another part of the decreased length of stay for those receiving MMA.
We had hypothesized that any decrease in inpatient narcotic consumption might lead to a decrease in the risk for dependence on opioid analgesics after discharge. However, despite the decrease in inpatient narcotic consumption with MMA, the current study suggests that the MMA protocol may not decrease the risk for narcotic dependence during the months after surgery. As a result, these data suggest that the postdischarge analgesia plans for patients receiving MMA versus PCA protocols need not differ. To our knowledge, such results have not been previously reported regarding PCA versus MMA for any orthopaedic procedure.
The present study has several limitations. First, all cases were performed by a single surgeon at a single center, limiting generalizability. Second, this was not a randomized study, introducing the possibility of selection bias. While patients receiving MMA versus PCA did not differ in most of the demographic variables, patients receiving PCA did have a higher comorbidity burden and were more likely to be smokers. Finally, it is possible that our study is underpowered to detect a difference in postoperative pain.
Overall, patients who received the MMA protocol experienced a lower rate of inpatient narcotic consumption than patients who received the PCA protocol. The difference in narcotic consumption is one potential explanation for the observed decreases in hospital length of stay and frequency of nausea/vomiting. Critically, patients receiving MMA did not report increased pain during the inpatient stay. Minimizing the risks of analgesia without decreasing its effectiveness is a crucial component of caring for ACDF patients postoperatively. This study highlights several benefits of an MMA protocol compared with the traditional approach using PCA.
Key Points
Patients who received MMA had a lower rate of inpatient narcotic consumption (2.5 vs. 5.8 oral morphine equivalents/h, P < 0.001). Patients who received MMA were less likely to have nausea/vomiting (5.5% vs. 37.5% P < 0.001). Patients who received MMA had a shorter hospital length of stay (27.3 vs. 40.1 h, P < 0.001). There was no difference between groups in visual analogue pain scale during postoperative day zero (4.7 for MMA vs. 5.2 for PCA, P ¼ 0.126) or during postoperative day one (4.1 for MMA vs. 4.1 for PCA, P ¼ 0.937). There was no difference between groups in the rate of narcotic dependence at the first (P ¼ 0.626) or second (P ¼ 0.480) postoperative visit. 
